Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide

NCT06230523

Eli Lilly · Phase 2 · Completed · Enrollment 263

NCT06230523

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebon/rn/rn/rn/rn/r
1 mg Eloralintiden/rn/rn/rn/rn/r
3 mg Eloralintiden/rn/rn/rn/rn/r
6 mg Eloralintiden/rn/rn/rn/rn/r
9 mg Eloralintiden/rn/rn/rn/rn/r
6/9 mg Eloralintiden/rn/rn/rn/rn/r
3/6/9 mg Eloralintiden/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.